Effect of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) by Composite Physiologic Index (CPI) at Baseline
A. Wells, K. Highland, S. Gläser, H. Nunes, J.W. Song, W. Wuyts, C. Stock, M. Alves, M. Padilla, on behalf of the SENSCIS trial investigators
{"title":"Effect of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) by Composite Physiologic Index (CPI) at Baseline","authors":"A. Wells, K. Highland, S. Gläser, H. Nunes, J.W. Song, W. Wuyts, C. Stock, M. Alves, M. Padilla, on behalf of the SENSCIS trial investigators","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2433","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":131426,"journal":{"name":"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2433","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
